Findings from OMRF could clarify a lingering mystery about chemical changes in the brain that occur during stress-induced drug abuse relapse of methamphetamine and cocaine.
Research will focus on the brain’s reward pathways that respond to opioids.
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 for research on dopamine’s role in Alzheimer’s disease.
For years, the terms “Alzheimer’s” and “dementia” have been used interchangeably. But the difference between them is important.
OMRF awarded scientific prizes to four scientists and honored a board member on Tuesday at its spring board meeting.
Alzheimer’s affects 5.8 million Americans, and one in three senior citizens dies with the disease or other forms of dementia.